Recently the DEA announced their intention to reschedule 5 lesser known promising psychedelic compounds with no apparent reason. Led by biotechnology company Panacea Plant Sciences and friends, the natural products research community pushed back against the DEA, ultimately taking them to court. And to most of the community’s surprise, this effort proved successful. In this conversation we sit down with David Heldreth, Jr. of Panacea Plant Sciences to get his perspective on this story while reflecting on the absurdity of having to fight to protect access to natural compounds for research. Isn’t life curious?
Learn more about Panacea Plant Sciences: https://panaceaplantsciences.net/
The DEA’s original proposed rule to schedule 5 psychedelics: https://www.federalregister.gov/documents/2022/01/14/2022-00713/schedules-of-controlled-substances-placement-of-4-hydroxy-nn
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
Death, Sex & Money
Anna Sale explores the big questions and hard choices that are often left out of polite conversation.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.